Last reviewed: June 23, 2026

Last updated: June 23, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Obesity reduces fertility rates by up to 40% in women and affects sperm quality and sexual function in men. Weight loss through GLP-1 therapy can restore hormonal balance, improve ovulation, and increase the likelihood of successful conception. PlexusDx offers compounded semaglutide injections starting at $149/mo to help you reach a healthier weight—and potentially improve your reproductive health.

How Excess Weight Affects Fertility and Pregnancy Success

Carrying extra pounds disrupts the delicate balance of hormones required for reproduction. Insulin resistance, a hallmark of obesity, triggers higher androgen levels in women, which can prevent ovulation and interfere with egg quality. Men with obesity often experience reduced testosterone production and lower sperm motility, both critical factors in conception.

Polycystic ovary syndrome (PCOS), strongly linked to weight gain, affects 1 in 10 reproductive-age women and is a leading cause of infertility. The condition creates a vicious cycle: weight gain worsens PCOS, and PCOS makes weight loss harder. Inflammatory markers rise with excess body fat, further disrupting reproductive hormones like luteinizing hormone (LH) and follicle-stimulating hormone (FSH).

Studies show that women losing just 5–10% of body weight often restore regular menstrual cycles and improve egg quality within 3–6 months. Pregnancy rates increase measurably after weight loss, particularly in those with PCOS or obesity-related infertility.

The Role of GLP-1 Therapy in Restoring Metabolic and Reproductive Health

GLP-1 receptor agonists like semaglutide work by improving insulin sensitivity and reducing inflammation throughout the body. By lowering insulin resistance, these medications allow hormone-producing glands to function more normally, which naturally restores estrogen and progesterone balance in women. Men often see improvements in sexual function and testosterone levels as insulin sensitivity improves.

Semaglutide reduces belly fat preferentially, which is metabolically active tissue that produces excess estrogen and inflammatory compounds. Shrinking visceral fat reserves helps normalize the hormone environment needed for regular ovulation and healthy sperm production. Clinical data shows GLP-1 therapy produces steady, sustainable weight loss—the kind most likely to stick and support long-term fertility improvements.

Beyond weight loss, GLP-1 medications reduce appetite-driven eating patterns that often sabotage fertility-focused lifestyle changes. Patients report greater compliance with healthy habits, making it easier to maintain weight loss gains that support reproductive success.

Clinical Evidence Linking Weight Loss to Improved Fertility Outcomes

A 2023 systematic review found that women who lost 10% or more of body weight had a 29% increase in successful pregnancy rates compared to those who did not lose weight. Among women with PCOS specifically, weight loss improved ovulation rates by up to 50% and increased live birth rates in fertility treatment cycles. These results held even when weight loss was modest and gradual.

Male fertility studies show similar promise: a 10% weight reduction correlates with improved sperm concentration, motility, and morphology within 4–6 months. Erectile dysfunction and low libido, common in men with obesity, often resolve with sustained weight loss of 5–15%. The reproductive system is sensitive to metabolic health, and GLP-1 therapy's dual effect—rapid initial weight loss followed by steady maintenance—creates ideal conditions for fertility improvement.

PlexusDx patients using compounded semaglutide injections report not only weight loss but also renewed confidence in their reproductive potential. The combination of medical support and personalized dosing increases adherence and success rates.

Practical Steps to Support Fertility While Using Semaglutide

If you are trying to conceive, inform your healthcare provider so they can monitor your weight loss trajectory and ensure it aligns with fertility goals. Rapid weight loss can temporarily disrupt cycles, so a moderate, steady approach (1–2 pounds per week) is often safer for reproductive health. Nutrient-dense eating—rich in folate, iron, zinc, and omega-3s—supports both weight loss and egg and sperm quality during semaglutide therapy.

PlexusDx's Precision Peptide Genetic Test identifies your personal metabolic profile across 14 pathways and 49 peptides, revealing how genetic factors like FTO rs9939609 and MC4R rs17782313 variants may affect your weight loss response and fertility. Understanding your genetic predispositions helps your provider optimize your semaglutide dose and lifestyle plan for maximum reproductive benefit. The test costs just $99 after your first month of treatment and gives you actionable insights into your unique body.

Combine semaglutide therapy with regular moderate exercise (150 minutes weekly), adequate sleep (7–9 hours), and stress management—all proven to boost fertility alongside weight loss. Track your cycle, monitor hormonal signs, and work with your fertility specialist to time conception attempts as your weight normalizes.

Why Choose PlexusDx for Your Weight Loss and Fertility Journey

PlexusDx offers compounded semaglutide injections from licensed 503A compounding pharmacies—the same quality standard used in clinical research. Starting at just $149/mo with no insurance required, no membership fee, and HSA/FSA eligibility, PlexusDx makes fertility-supporting weight loss accessible. Your dose may need to go up as your body responds, but your price stays the same—a transparent, patient-centered approach.

All 50 states are served, and PlexusDx integrates genetic testing to personalize your treatment plan. Whether you choose semaglutide injections, oral semaglutide, tirzepatide, or the dual-compound GLP-Squared formulation, PlexusDx ensures you receive consistent, high-quality medication tailored to your reproductive and metabolic goals. Start your fertility-focused weight loss journey today with expert medical support and transparent pricing.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I take semaglutide while trying to get pregnant?

Semaglutide is not recommended during pregnancy itself, but weight loss before conception significantly improves fertility. Discuss your conception timeline with your doctor; most providers recommend reaching goal weight and maintaining it for a few months before attempting pregnancy. PlexusDx providers can help you plan a fertility-focused treatment timeline.

How much weight do I need to lose to improve my fertility?

Clinical evidence shows that losing just 5–10% of body weight can restore ovulation and improve hormone balance in many women. Men often see reproductive improvements with similar losses. PlexusDx's compounded semaglutide helps you achieve steady, sustainable weight loss that supports fertility goals without dangerous rapid changes.

Is compounded semaglutide as effective as brand-name Wegovy for fertility improvement?

PlexusDx compounded semaglutide from licensed 503A pharmacies contains the same active ingredient as Wegovy and works through identical mechanisms. The clinical benefits for weight loss and fertility improvement are the same, but PlexusDx costs less (starting at $149/mo) and requires no insurance. Effectiveness depends on adherence and dose optimization, which PlexusDx providers support throughout your journey.

What if my fertility problems are not related to weight?

While weight significantly impacts fertility, other factors like age, hormone imbalances, and structural issues also play roles. PlexusDx recommends working with both a weight loss provider and a fertility specialist to address all contributing factors. Even if weight is not the only issue, reducing it improves fertility odds and overall health.

Can the Precision Peptide Genetic Test help predict my fertility response to semaglutide?

The Precision Peptide Genetic Test (add-on, $99 after first month) maps 14 metabolic pathways and reveals how variants like GIPR rs1800437, GLP1R rs6923761, and FTO rs9939609 affect your weight loss response. While not a fertility-specific test, understanding your metabolic predispositions helps optimize semaglutide dosing for faster, more sustainable weight loss—which directly improves reproductive outcomes. PlexusDx uses these insights to personalize your treatment plan.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves